Journal
CELL STEM CELL
Volume 6, Issue 6, Pages 517-520Publisher
CELL PRESS
DOI: 10.1016/j.stem.2010.05.012
Keywords
-
Categories
Ask authors/readers for more resources
Human stem cell biology is driving the promise of novel regenerative therapies into clinical trials. Although the pharmaceutical industry has embraced stem cells as tools in drug discovery, few companies have taken the risk to deliver stem cell-based medicines. Here, we evaluate the various cell-based opportunities and corporate strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available